SFM
MBOT icon

Signet Financial Management’s Microbot Medical MBOT Stock Holding History

Signet Financial Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed – – 581
2018
Q3 		$0 Buy
+2
New +$17 ﹤0.01% 1018
2018
Q2 		– Hold
0
– – – 1048
2018
Q1 		– Hold
0
– – – 917

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Signet Financial Management's MBOT Position: Q4 2018 in Review

Signet Financial Management sold out of Microbot Medical (MBOT) in Q4 2018, closing a stake of 2 shares.

Signet Financial Management first reported a position in MBOT in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 29 funds tracked by Wall St. Rank hold MBOT as of Q4 2018.

  • Signet Financial Management reported no remaining Microbot Medical position as of Q4 2018 after selling out during the quarter.
  • Signet Financial Management sold 2 Microbot Medical shares in Q4 2018.
  • Signet Financial Management first reported a position in Microbot Medical in Q3 2018 and held it in 1 quarter.
  • Signet Financial Management's Microbot Medical position peaked at $0 in Q3 2018.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2018.

Based on Signet Financial Management's 13F filing for Q4 2018, filed 14 Feb 2019.